Will Parker

Papers

Total Citations

H-Index

About

Dr. Will Parker is a leading urologic surgeon and researcher whose work centers on optimizing perioperative care and recovery for patients undergoing major oncologic surgery, particularly radical cystectomy. His most notable contribution is the landmark study, "Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy" (2015, 19 citations), which demonstrated that incorporating the μ-opioid receptor antagonist alvimopan into a structured enhanced recovery after surgery (ERAS) protocol significantly accelerates gastrointestinal recovery and reduces hospital length of stay. This work has helped establish a new standard of care, directly improving patient outcomes by mitigating the common and debilitating complication of post-operative ileus. Dr. Parker’s research bridges the gap between pharmacologic innovation and practical clinical pathways, showing how targeted interventions can transform recovery trajectories. His findings have been widely adopted in high-volume cystectomy centers, influencing perioperative guidelines and underscoring the value of multimodal, evidence-based recovery programs. Through this focused yet impactful contribution, Dr. Parker has advanced the field of urologic oncology by making major surgery safer and more tolerable for patients.